Troubling news from Asia about treating enteric fever: a coming storm
In The Lancet Infectious Diseases, Amit Arjyal and colleagues report the results from their randomised clinical trial comparing gatifl oxacin with ceftriaxone for patients with uncomplicated enteric fever in Nepal. Their two main fi ndings are sobering. First, they suggest that fl uoroquinolones should...
Uloženo v:
Hlavní autor: | Ryan, Edward T |
---|---|
Médium: | Technical Report |
Jazyk: | en_US |
Vydáno: |
Lancet Infect Dis 2016
2016
|
Témata: | |
On-line přístup: | http://103.69.126.140:8080/handle/123456789/817 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|
Podobné jednotky
-
Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomized controlled trial
Autor: Arjyal, Amit, a další
Vydáno: (2016) -
Study on incidence of Nalidixic acid resistant Salmonella enterica serovar Typhi and Salmonella entrica serovar Paratyphi A and their antibiotic susceptibilities.
Autor: Giri, Shudij
Vydáno: (2012) -
Control of yellow fever Field Guide
Vydáno: (2005) -
Frequently asked questions on chikungunya fever
Vydáno: (2013) -
Knowledge, attitude and practice regarding dengue fever among the healthy population of highland and lowland communities in central Nepal.
Autor: Dhimal, Meghnath Aryal, Krishna Kumar Dhimal, Mandira Lamichhane Gautam, Ishan Singh, Shanker Pratap Bhusal, Chop Lal Kuch, Ulrich
Vydáno: (2014)